Alkermes plc

NASDAQ:ALKS

24.81 (USD) • At close June 13, 2024
Bedrijfsnaam Alkermes plc
Symbool ALKS
Munteenheid USD
Prijs 24.81
Beurswaarde 4,198,373,010
Dividendpercentage 0%
52-weken bereik 22.01 - 33.71
Industrie Biotechnology
Sector Healthcare
CEO Mr. Richard F. Pops
Website https://www.alkermes.com

An error occurred while fetching data.

Over Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and

Vergelijkbare Aandelen

Evotec SE logo

Evotec SE

EVO

8.69 USD

Premier, Inc. logo

Premier, Inc.

PINC

18.46 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

80.08 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

394.1 USD

Omnicell, Inc. logo

Omnicell, Inc.

OMCL

27.23 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

119.61 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

42.56 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

45.45 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

113.5 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)